Literature DB >> 35897866

One-Pot Route from Halogenated Amides to Piperidines and Pyrrolidines.

Qiao Song1,2, Sheng Wang1, Xiangui Lei1,2, Yan Liu1, Xin Wen1, Zhouyu Wang1,2.   

Abstract

Piperidine and pyrrolidine derivatives are important nitrogen heterocyclic structures with a wide range of biological activities. However, reported methods for their construction often face problems of requiring the use of expensive metal catalysts, highly toxic reaction reagents or hazardous reaction conditions. Herein, an efficient route from halogenated amides to piperidines and pyrrolidines was disclosed. In this method, amide activation, reduction of nitrile ions, and intramolecular nucleophilic substitution were integrated in a one-pot reaction. The reaction conditions were mild and no metal catalysts were used. The synthesis of a variety of N-substituted and some C-substituted piperidines and pyrrolidines became convenient, and good yields were obtained.

Entities:  

Keywords:  amide activation; one-pot route; piperidine; pyrrolidine; synthesis

Mesh:

Substances:

Year:  2022        PMID: 35897866      PMCID: PMC9331508          DOI: 10.3390/molecules27154698

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.927


1. Introduction

Piperidine and pyrrolidine derivatives are important nitrogen heterocyclic structures with a wide range of biological activities [1,2,3,4,5]. For example, the first synthetic analgesic drug, pethidine, is a powerful analgesic still commonly used in clinical practice [6] (Figure 1, 1). Domperidone is a dopamine receptor antagonist that is used to treat digestive disorders [7] (Figure 1, 2). Levobupivacaine is clinically used as a long-acting local anesthetic that inhibits the release of γ-aminobutyric acid in the brain [8] (Figure 1, 3). Bepridil is a long-acting calcium antagonist clinically used to treat angina pectoris, arrhythmia, and hypertension [9] (Figure 1, 4). Buflomedil is a vasoactive drug with many pharmacological effects. It is widely used in the treatment of cerebrovascular and peripheral vascular diseases [10] (Figure 1, 5).
Figure 1

Drugs containing piperidine or pyrrolidine structure.

The reported methods for the construction of piperidines and pyrrolidines are mainly divided into two categories. The first type is the reduction method, in which expensive metal catalysts, such as palladium and platinum, are used to catalyze the hydrogenation reduction of pyridines or pyrroles [11,12,13,14,15]. Moreover, the reaction usually needs to be conducted at a high pressure of tens to hundreds of atmospheres. The other type is the cyclization reaction, in which cyclic amines are constructed by nucleophilic substitution of primary amines with dihaloalkanes or diols [16,17]. However, dihaloalkanes are strong alkylating agents with high genotoxicity, and the methods using diols also face the problem of requiring a high reaction temperature of over 200 °C. Amides are a class of relatively stable carbonyl compounds that do not readily undergo reactions in contrast to acyl halides, anhydrides, and esters. However, a significant body of research on the selective activation of amides to achieve powerful transformations under mild conditions has emerged in recent decades [18,19,20,21,22,23,24]. In 2017, Huang’s group reported an interesting method that involves the amide activation-induced dehydracoupling of halogenated secondary amides with alkenes and NaBH4-triggered tandem cyclization reaction; the method is used to efficiently construct 2-allyl piperidines and pyrrolidines [25]. In 2021, our group disclosed a route from aryl ethylamide to fused indolizidines and quinolizidines [26]. In this method, the following are integrated in a one-pot reaction: amide activation, Bischler–Napieralski reaction (B–N reaction) [27,28], imine reduction, and intramolecular nucleophilic substitution. We found that if the reaction is always controlled at a lower temperature, then the B–N reaction will be inhibited. Through this, the main product of piperidines or pyrrolidines was obtained rather than the fused indolizidines and quinolizidines. In the present study, a one-pot route that involved the use of halogenated amides to construct piperidine and tetrahydropyrrole derivatives was disclosed (Scheme 1c).
Scheme 1

Comparison of previous works and this work. (a) Huang’s work; (b) Our previous work; (c) This work.

2. Results and Discussion

Reaction conditions were optimized by using 5-chloro-N-(4-chlorolphenethyl)pentanamide (6a) as the starting material. Considering that pyridine class Lewis base plays an important role in the activation of amide, different kinds of base were first screened (Table 1, Entries 1–5). 2-Fluoropyridine (2-F-Py) was the most efficient (Table 1, Entry 4). When Lewis base was absent, the reaction still occurred, but the yield was reduced to a great extent (Table 1, Entry 6). Nevertheless, increasing the amount of 2-F-Py did not contribute to the improvement of yield (Table 1, Entry 7). The reaction temperature was subsequently investigated. When the reaction temperature was increased, the yield of the product decreased. (Table 1, Entries 8–9). This was due to the involving of B–N reaction at relatively higher temperatures, resulting in the production of some polycyclic byproducts. Different reductants, including KBH4, NaBH3CN, and NaBH(OAc)3, were then tested, but the outcomes were inferior to when NaBH4 was used (Table 1, Entries 10–12).
Table 1

Optimization of reaction conditions a.

EntryBaseReaction T (°C)ReductantYield (%) b
1Pyridine (1.2 equiv.)-−78NaBH428
23,5-dimethylpyridine (1.2 equiv.)−78NaBH432
32-Cl-Py (1.2 equiv.)−78NaBH450
4 2-F-Py (1.2 equiv.) −78 NaBH4 90
52-I-Py (1.2 equiv.)−78NaBH440
6-−78NaBH412
72-F-Py (2.0 equiv.)−78NaBH485
82-F-Py (1.2 equiv.)−30NaBH473
92-F-Py (1.2 equiv.)0NaBH466
102-F-Py (1.2 equiv.)−78KBH475
112-F-Py (1.2 equiv.)−78NaBH3CN40
122-F-Py (1.2 equiv.)−78NaBH(OAc)3trace

a Reaction conditions: 6a (0.5 mmol), Tf2O (1.1 equiv.), base, CH2Cl2 (5 mL), Ar, reaction temp., 30 min → reductant (2.0 equiv.), MeOH (5 mL), r.t., 2 h. b Yields were determined by 1H NMR with 1,1,2,2-tetrachloroethane as the internal standard.

With the optimized reaction conditions defined, the scope of the reaction was investigated. N-phenethyl chloropentamides were tested first (Scheme 2, 7a–7e). Substrates with electron-donating or electron-withdrawing substitutions in the aromatic nucleus all reacted smoothly to generate corresponding N-phenethyl piperidines. The reaction system was then applied to N-benzyl amides (Scheme 2, 7f–7h). Various N-benzyl piperidines were obtained at moderate-to-good yields. Aliphatic chain and cyclic amide substrates adapted well under the established conditions and transformed into piperidine derivatives at good yields (Scheme 2, 7i–7j). Halogenated butyramides were subsequently tested. Similar to piperidine derivatives, tetrahydropyrrole derivatives with versatile substitutions were also successfully synthesized (Scheme 2, 7k–7t). We also attempted to synthesize C-substituted pyrrolidine. A 3-bromo-substituted pyrrolidine was successfully obtained in this method (Scheme 2, 7u).
Scheme 2

Scope of this method a: For each compound, the isolated yield is given as a percentage. a Uniform reaction conditions unless otherwise noted: Compound 6 (0.5 mmol), Tf2O (1.1 equiv.), 2-F-Py (1.2 equiv.), CH2Cl2 (5 mL), Ar, −78 °C, 30 min → MeOH (5 mL), NaBH4 (2.0 equiv.), r.t., 2 h.

We further attempted the synthesis of three-, four-, and seven-membered ring compounds. Unfortunately, none of these compounds were obtained, even if trace amounts were detected through mass spectrometry. The main products were uncycled secondary amines, which were confirmed by HRMS. Possibly, the ring tension made the reaction more difficult (Scheme 2, 7v). The synthesis of N-arylpyrrolidines was also difficult. The weaker nucleophilicity of arylamines than aliphatic amines may be the main factor that led to this result (Scheme 2, 7w). (See Supplementary Materials) A plausible mechanism is illustrated in Scheme 3, with compound 7a as an example. Amide substrate (Scheme 3, 6a) was firstly activated by Tf2O to obtain a nitrilium ion [29,30] (Scheme 3, 8), which was reduced by sodium borohydride to obtain the imide ion (Scheme 3, 9). The imide ion 9 was further reduced by sodium borohydride to obtain the halogenated secondary amine [31], and this was followed by intramolecular nucleophilic substitution to obtain piperidine product (Scheme 3, 7a). In our previous work [26], the nitrilium ion 8 was readily attacked by electrons on the benzene ring and underwent the B–N reaction to form the imine ion (Scheme 3, 11) under 40 °C. Imine ion 11 was then subjected to reduction of the C=N bond (Scheme 3, 12) followed by intramolecular nucleophilic substitution to obtain a fused indolizidine product (Scheme 3, 13). However, in this work, it was difficult for the electrons on the benzene ring to attack imine ion 11 at a low temperature, so the B–N reaction was inhibited. As a result, a piperidine was obtained other than a fused indolizidine.
Scheme 3

The proposed mechanism.

3. Materials and Methods

3.1. General Informations

All solvents were distilled from appropriate drying agents prior to use. CH2Cl2 was distilled over calcium hydride under a nitrogen atmosphere and stored over 4Å MS. Tf2O was distilled over phosphorous pentoxide (P2O5) and was stored for no more than a week before redistilling. Flash column chromatography was performed using silica gel (300–400 mesh). 1H NMR and 13C NMR (400 and 101 MHz, respectively) spectra were recorded on a Bruker 400 MHz NMR spectrometer in CDCl3. 1H NMR chemical shifts were reported in ppm (δ) relative to tetramethylsilane (TMS) with the solvent resonance employed as the internal standard (CDCl3, 7.26 ppm). 13C NMR chemical shifts were reported in ppm from TMS with the solvent resonance as the internal standard (CDCl3, 77.16 ppm). HRMS data were recorded on a SCIEX X500R QTOF HRMS apparatus.

3.2. General Procedure A for the Synthesis of Piperidines and Pyrrolidines

Into a dry 25 mL round-bottom flask equipped with a magnetic stirring bar, the following were added successively: a secondary amide (compound 6, 0.5 mmol, 1.0 equiv.), 10 mL of anhydrous CH2Cl2 and 2-F-Py (0.6 mmol, 1.2 equiv.) under an argon atmosphere. After being cooled to −78 °C, Tf2O (0.55 mmol, 1.1 equiv.) was added dropwise via a syringe, and the reaction was stirred for 30 min. Then, NaBH4 (1.0 mmol, 2 equiv.) and CH3OH (5 mL) were added under r.t. and stirred for additional 2 h. The reaction was quenched with a saturated aqueous solution of NaHCO3 (10 mL), and the mixture was extracted with dichloromethane (3 × 8 mL). The combined organic phase was dried over anhydrous Na2SO4, filtered and concentrated under reduced pressure. The residue was purified by flash chromatography on silica gel to give the corresponding compound.

4. Conclusions

In summary, we proposed a facile tandem protocol to construct piperidines and pyrrolidines. This method integrated amide activation, reduction of nitrile ions, and intramolecular nucleophilic substitution in a one-pot reaction. This method had mild reaction conditions and produced a variety of N-substituted and some C-substituted piperidines and pyrrolidines at good yields.
  26 in total

1.  A Rhodium Nanoparticle-Lewis Acidic Ionic Liquid Catalyst for the Chemoselective Reduction of Heteroarenes.

Authors:  Alena Karakulina; Aswin Gopakumar; İsmail Akçok; Bastien L Roulier; Thomas LaGrange; Sergey A Katsyuba; Shoubhik Das; Paul J Dyson
Journal:  Angew Chem Int Ed Engl       Date:  2015-11-18       Impact factor: 15.336

2.  The value of population pharmacokinetics and simulation for postmarketing safety evaluation of dosing guidelines for drugs with a narrow therapeutic index: buflomedil as a case study.

Authors:  Laurent Bourguignon; Michel Ducher; David Matanza; Nathalie Bleyzac; Mathieu Uhart; Emmanuel Odouard; Pascal Maire; Sylvain Goutelle
Journal:  Fundam Clin Pharmacol       Date:  2011-10-17       Impact factor: 2.748

3.  Levobupivacaine for epidural analgesia in labor: the sparing effect of epidural fentanyl.

Authors:  A P Robinson; G R Lyons; R C Wilson; H J Gorton; M O Columb
Journal:  Anesth Analg       Date:  2001-02       Impact factor: 5.108

4.  Ru-catalyzed β-selective and enantioselective addition of amines to styrenes initiated by direct arene-exchange.

Authors:  Maiko Otsuka; Hiroya Yokoyama; Kohei Endo; Takanori Shibata
Journal:  Org Biomol Chem       Date:  2012-04-05       Impact factor: 3.876

5.  Synthesis, β-hematin inhibition studies and antimalarial evaluation of new dehydroxy isoquine derivatives against Plasmodium berghei: A promising antimalarial agent.

Authors:  Edgar A Valverde; Angel H Romero; María E Acosta; Neira Gamboa; Genesis Henriques; Juan R Rodrigues; Carlos Ciangherotti; Simón E López
Journal:  Eur J Med Chem       Date:  2017-10-18       Impact factor: 6.514

Review 6.  Recent advancement of piperidine moiety in treatment of cancer- A review.

Authors:  Pallavi Goel; Ozair Alam; Mohd Javed Naim; Farah Nawaz; Muzaffar Iqbal; Md Iqbal Alam
Journal:  Eur J Med Chem       Date:  2018-08-08       Impact factor: 6.514

7.  NMDA receptor affinities of 1,2-diphenylethylamine and 1-(1,2-diphenylethyl)piperidine enantiomers and of related compounds.

Authors:  Michael L Berger; Anna Schweifer; Patrick Rebernik; Friedrich Hammerschmidt
Journal:  Bioorg Med Chem       Date:  2009-03-19       Impact factor: 3.641

8.  Palladium-Catalyzed Formal Cross-Coupling of Diaryl Ethers with Amines: Slicing the 4-O-5 Linkage in Lignin Models.

Authors:  Huiying Zeng; Dawei Cao; Zihang Qiu; Chao-Jun Li
Journal:  Angew Chem Int Ed Engl       Date:  2018-03-05       Impact factor: 15.336

Review 9.  Amide activation: an emerging tool for chemoselective synthesis.

Authors:  Daniel Kaiser; Adriano Bauer; Miran Lemmerer; Nuno Maulide
Journal:  Chem Soc Rev       Date:  2018-10-29       Impact factor: 54.564

Review 10.  Pyrrolidine in Drug Discovery: A Versatile Scaffold for Novel Biologically Active Compounds.

Authors:  Giovanna Li Petri; Maria Valeria Raimondi; Virginia Spanò; Ralph Holl; Paola Barraja; Alessandra Montalbano
Journal:  Top Curr Chem (Cham)       Date:  2021-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.